Cargando…
SARS-CoV-2 targets the liver and manipulates glucose metabolism
A recent publication by Barreto and colleagues showed that SARS-CoV-2 directly triggers hyperglycemia by infecting hepatocytes and inducing phosphoenolpyruvate carboxykinase (PEPCK)-dependent gluconeogenesis. Here, we discuss the biological importance of these findings, including the hepatic tropism...
Autores principales: | Pirola, Carlos J., Sookoian, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247144/ https://www.ncbi.nlm.nih.gov/pubmed/37330366 http://dx.doi.org/10.1016/j.molmed.2023.06.001 |
Ejemplares similares
-
Pangolins Harbor SARS-CoV-2-Related Coronaviruses
por: Han, Guan-Zhu
Publicado: (2020) -
Tracking the Genomic Footprints of SARS-CoV-2 Transmission
por: Lam, Tommy Tsan-Yuk
Publicado: (2020) -
Using Genetics To Dissect SARS-CoV-2 Infection
por: Brest, Patrick, et al.
Publicado: (2021) -
The Mystery of MIS-C Post-SARS-CoV-2 Infection
por: Brodsky, Nina N., et al.
Publicado: (2020) -
Hijacking of host mitochondria by Toxoplasma gondii and SARS-CoV-2
por: Zhang, Ruize, et al.
Publicado: (2022)